Eldozide V Tablet
By Eldozide V
Rx
10 Tablet in a Strip

Composition
Voglibose(0.2mg) + Metformin(500mg) + Gliclazide(60mg)

Manufacturer - El-Dorado Bio-Tech Pvt Ltd
74/01, Sector G.C, CIDCO, Waluj, Aurangabad (MS)

Expires on or after
September, 2026

liver
It is important to be cautious when using Sucrazide MV 0.2mg/500mg/60mg Tablet in patients with liver disease. Adjusting the dose of this medication may be necessary, so please seek advice from your doctor. Typically, treatment with Sucrazide MV 0.2mg/500mg/60mg Tablet begins with a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease. If you have liver issues, consult your doctor before taking Sucrazide MV 0.2mg/500mg/60mg Tablet.

kidney
Sucrazide MV 0.2mg/500mg/60mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, and it's not recommended for severe kidney disease. Regular kidney function monitoring is advised during treatment.

alcohol
It is important to avoid consuming alcohol while taking Sucrazide MV 0.2mg/500mg/60mg Tablet to ensure safety. Avoid alcohol intake with this medication.

driving
When using Sucrazide MV 0.2mg/500mg/60mg Tablet, do not drive if you experience low or high blood sugar symptoms that may affect your driving abilities.

pregnancy
Sucrazide MV 0.2mg/500mg/60mg Tablet may not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing this medication. Please consult your doctor before using Sucrazide MV 0.2mg/500mg/60mg Tablet during pregnancy.

breastfeeding
During breastfeeding, be cautious when using Sucrazide MV 0.2mg/500mg/60mg Tablet. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is no longer in her body.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹102
₹120
15% OFF
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
